US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

7 deals · US$7.6bndisclosed · Ophthalmology · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Feb 2026 LKC Technologies DW Healthcare PartnersAMETEKAcquisitionAnnounced–Medtech+2 William Blair (sell-side)
Mar 2026 EyeSouth Partners’ retina business EyeSouth PartnersCencoraAsset saleAnnounced1,100.0Healthcare Services+1 Jefferies (sell-side)Kirkland & Ellis (sell-side)BofA Securities (buy-side)Citi (buy-side)Sidley Austin (buy-side)
Mar 2026 Apellis Pharmaceuticals –BiogenAcquisitionAnnounced5,600.0Biotech+2 Lazard (buy-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)WilmerHale (sell-side)Cravath, Swaine & Moore (buy-side)
May 2026 Perfuse Therapeutics –BayerAcquisitionAnnounced300.0Biotech+2 Goodwin (sell-side)
Jul 2026 iRenix Medical –Tarsus PharmaceuticalsAcquisitionAnnounced75.0Ophthalmology+2 Piper Sandler (sell-side)DLA Piper (sell-side)Gunderson Dettmer (buy-side)
Aug 2026 TYRVAYA (varenicline solution) nasal spray 0.03 mg ViatrisHarrowAsset saleAnnounced30.0Pharma+1 Cravath, Swaine & Moore (sell-side)
Aug 2026 Alkeus Pharmaceuticals –Tarsus PharmaceuticalsAcquisitionAnnounced450.0Biotech+2 Jefferies (sell-side)Latham & Watkins (sell-side)Barclays (buy-side)Gunderson Dettmer (buy-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built